Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A pilot study combining primary busulfan-based haploidentical stem cell transplantation with GD2 antibody to treat high-risk neuroblastoma.

Bone marrow transplantation·2026
Same author

MYCN Amplification in RB1-Inactivated Retinoblastoma: Association With High-Risk Features.

Pediatric blood & cancer·2026
Same author

Adjuvant therapy for children treated by enucleation at diagnosis of retinoblastoma.

EJC paediatric oncology·2025
Same author

High Incidence and Impact of Suspected Exocrine Pancreatic Insufficiency in Patients Post-Hematopoietic Stem Cell Transplantation: A Single-Center Prospective Observational Study.

United European gastroenterology journal·2025
Same author

Everolimus with or without Mycophenolate Mofetil for Graft-versus-Host Disease Prophylaxis after Hematopoietic Stem Cell Transplantation in Children with Acute Kidney Injury: A Single-Center Retrospective Analysis.

Transplantation and cellular therapy·2025
Same author

Amniotic Fluid Embolism in a Patient Presenting for Induction of Labor for Cholestasis of Pregnancy.

Cureus·2024

Related Experiment Video

Updated: Jul 10, 2026

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

Addressing the translation gap in SCT donor selection.

David Higgins1, Madlen Reschke1,2, Jonas Seiler1

  • 1Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.

Frontiers in Immunology
|July 9, 2026
PubMed
Summary
This summary is machine-generated.

Machine learning (ML) can enhance hematopoietic stem cell transplantation (SCT) donor selection. Bridging the gap to clinical practice requires robust data strategies, prospective studies, and awareness of regulatory and resource challenges.

Keywords:
GRFSaGVHDadult SCTdonor selectionhuman stem cell transplantation (HSCT)machine learningpediatric SCTrelapse

More Related Videos

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness
08:53

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness

Published on: August 31, 2016

Using Quantitative Real-time PCR to Determine Donor Cell Engraftment in a Competitive Murine Bone Marrow Transplantation Model
10:11

Using Quantitative Real-time PCR to Determine Donor Cell Engraftment in a Competitive Murine Bone Marrow Transplantation Model

Published on: March 7, 2013

Related Experiment Videos

Last Updated: Jul 10, 2026

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness
08:53

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness

Published on: August 31, 2016

Using Quantitative Real-time PCR to Determine Donor Cell Engraftment in a Competitive Murine Bone Marrow Transplantation Model
10:11

Using Quantitative Real-time PCR to Determine Donor Cell Engraftment in a Competitive Murine Bone Marrow Transplantation Model

Published on: March 7, 2013

Area of Science:

  • Biomedical Informatics
  • Transplantation Science
  • Clinical Decision Support

Background:

  • Machine learning (ML) shows potential for improving donor selection in hematopoietic stem cell transplantation (SCT).
  • A significant gap exists between developing ML models and their clinical implementation in SCT.
  • Translational incubation projects highlight practical challenges in adopting research findings.

Purpose of the Study:

  • To provide a practitioner's perspective on translating ML-driven SCT donor selection tools into clinical practice.
  • To offer concrete recommendations for data strategy and translational methodology.
  • To raise awareness of critical factors impeding clinical adoption of ML tools.

Main Methods:

  • Analysis of experiences from a German federally-funded translational incubation project (2021-2023).
  • Formulation of prescriptions for data strategy, including rethinking registry data and establishing multi-center infrastructure.
  • Emphasis on prospective studies and broader clinical parameter integration, moving beyond retrospective validation.

Main Results:

  • Registry data requires significant adaptation for ML applications in SCT.
  • Multi-center data infrastructure is essential for successful ML implementation.
  • Prospective validation aligned with standard-of-care endpoints is crucial.
  • Clinical teams must anticipate regulatory burdens, resource needs, and market dynamics.

Conclusions:

  • The technical feasibility of ML-supported SCT donor selection is established.
  • Community data sharing provides a foundation for progress.
  • Future efforts should focus on practical implementation, addressing regulatory, resource, and adoption barriers, rather than solely on retrospective modeling.